Clinical Trial Update: Preventing Microalbuminuria in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update focusing on preventing microalbuminuria in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Diabetes | Phase 3 | Status: COMPLETED